共 9 条
[5]
C-Terminal Provasopressin (Copeptin) is Associated With Left Ventricular Dysfunction, Remodeling, and Clinical Heart Failure in Survivors of Myocardial Infarction[J] . Dominic Kelly,Iain B. Squire,Sohail Q. Khan,Paulene Quinn,Joachim Struck,Nils G. Morgenthaler,Joan E. Davies,Leong L. NG.Journal of Cardiac Failure . 2008 (9)
[6]
Comparison of Copeptin, B-Type Natriuretic Peptide, and Amino-Terminal Pro-B-Type Natriuretic Peptide in Patients With Chronic Heart Failure[J] . Stephanie Neuhold,Martin Huelsmann,Guido Strunk,Brigitte Stoiser,Joachim Struck,Nils G. Morgenthaler,Andreas Bergmann,Deddo Moertl,Rudolf Berger,Richard Pacher.Journal of the American College of Cardiology . 2008 (4)
[7]
C-Terminal Provasopressin (Copeptin) as a Novel and Prognostic Marker in Acute Myocardial Infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study[J] . Sohail Q. Khan,Onkar S. Dhillon,Russell J. O’Brien,Joachim Struck,Paulene A. Quinn,Nils G. Morgenthaler,Iain B. Squire,Joan E. Davies,Andreas Bergmann,Leong L. Ng.Circulation . 2007 (16)
[8]
Brain Natriuretic Peptide and Other Risk Markers for Outcome Assessment in Patients With Non–ST-Elevation Coronary Syndromes and Preserved Systolic Function[J] . Alberto Palazzuoli,Jaap Deckers,Anna Calabrò,Maria Stella Campagna,Ranuccio Nuti,Marcello Pastorelli,Anna Laura Pasqui,Fulvio Bruni,Alberto Auteri,Luca Puccetti.The American Journal of Cardiology . 2006 (10)